Spatially explicit prioritization of human antibiotics and antineoplastics in Europe

Accelrys Inc, 2011 Adriaenssens, 2010, European Surveillance of Antimicrobial Consumption (ESAC): outpatient systemic antimycotic and antifungal use in Europe, J Antimicrob Chemother, 65, 769, 10.1093/jac/dkq023 Adriaenssens, 2011, European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997–2009), J Antimicrob Chemother, 66, vi3 Adriaenssens, 2011, European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe (1997–2009), J Antimicrob Chemother, 66, vi37 Adriaenssens, 2011, European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe (1997–2009), J Antimicrob Chemother, 66, vi47, 10.1093/jac/dkr457 Al-Ahmad, 1999, Biodegradability of cefotiam, ciprofloxacin, meropenem, penicillin G, and sulfamethoxazole and inhibition of waste water bacteria, Arch Environ Contam Toxicol, 37, 158, 10.1007/s002449900501 Backhaus, 2000, The single substance and mixture toxicity of quinolones to the bioluminescent bacterium Vibrio fischeri, Aquat Toxicol, 49, 49, 10.1016/S0166-445X(99)00069-7 Balcioglu, 2003, Treatment of pharmaceutical wastewater containing antibiotics by O3 and O3/H2O2 processes, Chemosphere, 50, 85, 10.1016/S0045-6535(02)00534-9 Batt, 2007, Comparison of the occurrence of antibiotics in four full-scale wastewater treatment plants with varying designs and operations, Chemosphere, 68, 428, 10.1016/j.chemosphere.2007.01.008 Bercu, 2008, Human health risk assessments for three neuropharmaceutical compounds in surface waters, Regul Toxicol Pharmacol, 50, 420, 10.1016/j.yrtph.2008.01.014 Besse, 2008, Human pharmaceuticals in surface waters: implementation of a prioritization methodology and application to the French situation, Toxicol Lett, 176, 104, 10.1016/j.toxlet.2007.10.012 Birak, 2001, Travis and Arms revisited: a second look at a widely used bioconcentration algorithm, Toxicol Ind Health, 17, 163, 10.1191/0748233701th110oa Boxall, 2010, Veterinary medicines and the environment, Handb Exp Pharmacol, 291, 10.1007/978-3-642-10324-7_12 Boxall, 2003, Peer reviewed: are veterinary medicines causing environmental risks?, Environ Sci Technol, 37, 286A, 10.1021/es032519b Cabello, 2006, Heavy use of prophylactic antibiotics in aquaculture: a growing problem for human and animal health and for the environment, Environ Microbiol, 8, 1137, 10.1111/j.1462-2920.2006.01054.x Calamari, 2003, Strategic survey of therapeutic drugs in the Rivers Po and Lambro in Northern Italy, Environ Sci Technol, 37, 1241, 10.1021/es020158e Castiglioni, 2008, Novel homologs of the multiple resistance regulator marA in antibiotic-contaminated environments, Water Res, 42, 4271, 10.1016/j.watres.2008.07.004 Choong, 2006, A preliminary ecotoxicity study of pharmaceuticals in the marine environment, J Toxicol Environ Health A, 69, 1959, 10.1080/15287390600751371 Christen, 2010, Highly active human pharmaceuticals in aquatic systems: a concept for their identification based on their mode of action, Aquat Toxicol, 96, 167, 10.1016/j.aquatox.2009.11.021 Christensen, 1998, Pharmaceuticals in the environment—a human risk?, Regul Toxicol Pharmacol, 28, 212, 10.1006/rtph.1998.1253 Christensen, 2007, Mixture and single-substance toxicity of selective serotonin reuptake inhibitors toward algae and crustaceans, Environ Toxicol Chem, 26, 85, 10.1897/06-219R.1 Coenen, 2009, European Surveillance of Antimicrobial Consumption (ESAC): outpatient parenteral antibiotic treatment in Europe, J Antimicrob Chemother, 64, 200, 10.1093/jac/dkp135 Cooper, 2008, Preliminary risk assessment database and risk ranking of pharmaceuticals in the environment, Sci Total Environ, 398, 26, 10.1016/j.scitotenv.2008.02.061 Cunningham, 2009, Human health risk assessment from the presence of human pharmaceuticals in the aquatic environment, Regul Toxicol Pharmacol, 53, 39, 10.1016/j.yrtph.2008.10.006 Daughton, 1999, Pharmaceuticals and personal care products in the environment: agents of subtle change, Environ Health Perspect, 107, 907, 10.1289/ehp.99107s6907 Diamond, 2011, Prioritizing contaminants of emerging concern for ecological screening assessments, Environ Toxicol Chem, 30, 2385, 10.1002/etc.667 Doerr-MacEwen, 2006, Expert stakeholders' views on the management of human pharmaceuticals in the environment, Environ Manage, 38, 853, 10.1007/s00267-005-0306-z Dolliver, 2008, Antibiotic losses in leaching and surface runoff from manure-amended agricultural land, J Environ Qual, 37, 1227, 10.2134/jeq2007.0392 EC, 1986 EC, 1998 EC, 2001 ECDC, 2012 EEA, 2009 EEA, 2011 EMA, 2011 EMEA, 1999, Antibiotic resistance in the European Union associated with therapeutic use of veterinary medicines EMEA, 2006 Enick, 2007, Assessing the assessments: pharmaceuticals in the environment, Environ Impact Assess, 27, 707, 10.1016/j.eiar.2007.01.001 EPA US, 2011 EPA US, 2011 ESS, 2004 Eurostat, 2011 Eurostat, 2011 Eurostat, 2011 Eurostat, 2011 FASS, 2012 Fatta-Kassinos, 2011, Pharmaceutical residues in environmental waters and wastewater: current state of knowledge and future research, Anal Bioanal Chem, 399, 251, 10.1007/s00216-010-4300-9 Fent, 2006, Ecotoxicology of human pharmaceuticals, Aquat Toxicol, 76, 122, 10.1016/j.aquatox.2005.09.009 Fick, 2010, Predicted critical environmental concentrations for 500 pharmaceuticals, Regul Toxicol Pharmacol, 58, 516, 10.1016/j.yrtph.2010.08.025 Franco, 2008, Estimation of the soil–water partition coefficient normalized to organic carbon for ionizable organic chemicals, Environ Toxicol Chem, 27, 1995, 10.1897/07-583.1 Franco, 2010, A multimedia activity model for ionizable compounds: validation study with 2,4-dichlorophenoxyacetic acid, aniline, and trimethoprim, Environ Toxicol Chem, 29, 789, 10.1002/etc.115 Fu, 2009, Methods for estimating the bioconcentration factor of ionizable organic chemicals, Environ Toxicol Chem, 28, 1372, 10.1897/08-233.1 Golet, 2003, Environmental exposure assessment of fluoroquinolone antibacterial agents from sewage to soil, Environ Sci Technol, 37, 3243, 10.1021/es0264448 Golsteijn, 2012, Do interspecies correlation estimations increase the reliability of toxicity estimates for wildlife?, Ecotoxicol Environ Saf, 80, 238, 10.1016/j.ecoenv.2012.03.005 Halling-Sørensen, 1998, Occurrence, fate and effects of pharmaceutical substances in the environment—a review, Chemosphere, 36, 357, 10.1016/S0045-6535(97)00354-8 Hendriks, 2007, A new twist on an old regression: transfer of chemicals to beef and milk in human and ecological risk assessment, Chemosphere, 70, 46, 10.1016/j.chemosphere.2007.07.030 Hollander, 2007, Spatial variance in multimedia mass balance models: comparison of LOTOS-EUROS and SimpleBox for PCB-153, Chemosphere, 68, 1318, 10.1016/j.chemosphere.2007.01.035 Holten Lützhøft, 1999, Algal toxicity of antibacterial agents applied in Danish fish farming, Arch Environ Contam Toxicol, 36, 1, 10.1007/s002449900435 Huggett, 2003, A theoretical model for utilizing mammalian pharmacology and safety data to prioritize potential impacts of human pharmaceuticals to fish, Hum Ecol Risk Assess, 9, 1789, 10.1080/714044797 Huschek, 2004, Environmental risk assessment of medicinal products for human use according to European Commission recommendations, Environ Toxicol, 19, 226, 10.1002/tox.20015 IEEP, 2009 Jiang, 2010, Biotic and abiotic degradation of four cephalosporin antibiotics in a lake surface water and sediment, Chemosphere, 80, 1399, 10.1016/j.chemosphere.2010.05.048 Jones, 2001, Human pharmaceuticals in the aquatic environment a review, Environ Technol, 22, 1383, 10.1080/09593330.2001.11090873 Jørgensen, 2000, Drugs in the environment, Chemosphere, 40, 691, 10.1016/S0045-6535(99)00438-5 Junker, 2006, Biodegradability of 14C-labeled antibiotics in a modified laboratory scale sewage treatment plant at environmentally relevant concentrations, Environ Sci Technol, 40, 318, 10.1021/es051321j Kasprzyk-Hordern, 2007, Multi-residue method for the determination of basic/neutral pharmaceuticals and illicit drugs in surface water by solid-phase extraction and ultra performance liquid chromatography–positive electrospray ionisation tandem mass spectrometry, J Chromatogr A, 1161, 132, 10.1016/j.chroma.2007.05.074 Kay, 2005, Transport of veterinary antibiotics in overland flow following the application of slurry to arable land, Chemosphere, 59, 951, 10.1016/j.chemosphere.2004.11.055 Kemper, 2008, Veterinary antibiotics in the aquatic and terrestrial environment, Ecol Indic, 8, 1, 10.1016/j.ecolind.2007.06.002 Knapp, 2009, Evidence of increasing antibiotic resistance gene abundances in archived soils since 1940, Environ Sci Technol, 44, 580, 10.1021/es901221x Kools, 2008, A ranking of European veterinary medicines based on environmental risks, Integr Environ Assess Manag, 4, 399, 10.1897/IEAM_2008-002.1 Kools, 2008, Estimating the use of veterinary medicines in the European union, Regul Toxicol Pharmacol, 50, 59, 10.1016/j.yrtph.2007.06.003 Kostich, 2008, Risks to aquatic organisms posed by human pharmaceutical use, Sci Total Environ, 389, 329, 10.1016/j.scitotenv.2007.09.008 Kreuzig, 2005, Test-plot studies on runoff of sulfonamides from manured soils after sprinkler irrigation, Environ Toxicol Chem, 24, 777, 10.1897/04-019R.1 Kumar, 2010, Pharmaceuticals, personal care products and endocrine-disrupting chemicals in U.S. surface and finished drinking waters: a proposed ranking system, Sci Total Environ, 408, 5972, 10.1016/j.scitotenv.2010.08.048 Kümmerer, 2009, Antibiotics in the aquatic environment—a review—part I, Chemosphere, 75, 417, 10.1016/j.chemosphere.2008.11.086 Kümmerer, 2009, Antibiotics in the aquatic environment—a review—part II, Chemosphere, 75, 435, 10.1016/j.chemosphere.2008.12.006 Larsen, 2009, Can differences in medical drug compliance between European countries be explained by social factors: analyses based on data from the European Social Survey, round 2, BMC Public Health, 9, 145, 10.1186/1471-2458-9-145 Larsson, 2007, Effluent from drug manufactures contains extremely high levels of pharmaceuticals, J Hazard Mater, 148, 751, 10.1016/j.jhazmat.2007.07.008 Le Bris, 2004, Experimental study on the bioaccumulation of oxytetracycline and oxolinic acid by the blue mussel (Mytilus edulis). An evaluation of its ability to bio-monitor antibiotics in the marine environment, Mar Pollut Bull, 48, 434, 10.1016/j.marpolbul.2003.08.018 Li, 2010, Biodegradation and adsorption of antibiotics in the activated sludge process, Environ Sci Technol, 44, 3468, 10.1021/es903490h López-Serna, 2010, Fully automated determination of 74 pharmaceuticals in environmental and waste waters by online solid phase extraction–liquid chromatography-electrospray–tandem mass spectrometry, Talanta, 83, 410, 10.1016/j.talanta.2010.09.046 Molander, 2009, WikiPharma — a freely available, easily accessible, interactive and comprehensive database for environmental effect data for pharmaceuticals, Regul Toxicol Pharmacol, 55, 367, 10.1016/j.yrtph.2009.08.009 Mompelat, 2009, Occurrence and fate of pharmaceutical products and by-products, from resource to drinking water, Environ Int, 35, 803, 10.1016/j.envint.2008.10.008 Muñoz, 2010, Environmental and human health risk assessment of organic micro-pollutants occurring in a Spanish marine fish farm, Environ Pollut, 158, 1809, 10.1016/j.envpol.2009.11.006 Oaks, 2004, Diclofenac residues as the cause of vulture population decline in Pakistan, Nature, 427, 630, 10.1038/nature02317 Pedersen, 2005, Human pharmaceuticals, hormones, and personal care product ingredients in runoff from agricultural fields irrigated with treated wastewater, J Agric Food Chem, 53, 1625, 10.1021/jf049228m Perazzolo, 2010, Occurrence and fate of micropollutants in the Vidy Bay of Lake Geneva, Switzerland. Part I: priority list for environmental risk assessment of pharmaceuticals, Environ Toxicol Chem, 29, 1649 Phillips, 2010, Pharmaceutical formulation facilities as sources of opioids and other pharmaceuticals to wastewater treatment plant effluents, Environ Sci Technol, 44, 4910, 10.1021/es100356f Pistocchi, 2006, European hydraulic geometries for continental SCALE environmental modelling, J Hydrol, 329, 553, 10.1016/j.jhydrol.2006.03.009 Placket, 1952, Quantal responses to mixtures of poisons, J Roy Stat Soc B, 141 Ragas, 2011, Cumulative risk assessment of chemical exposures in urban environments, Environ Int, 37, 872, 10.1016/j.envint.2011.02.015 Research Triangle Institute, 2005 RIVM, 2011 Roberts, 2006, The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment, Sci Total Environ, 356, 143, 10.1016/j.scitotenv.2005.04.031 Roos, 2012, Prioritising pharmaceuticals for environmental risk assessment: towards adequate and feasible first-tier selection, Sci Total Environ, 421–422, 102, 10.1016/j.scitotenv.2012.01.039 Sanchez, 2011, Adverse effects in wild fish living downstream from pharmaceutical manufacture discharges, Environ Int, 37, 1342, 10.1016/j.envint.2011.06.002 Sanderson, 2004, Ranking and prioritization of environmental risks of pharmaceuticals in surface waters, Regul Toxicol Pharmacol, 39, 158, 10.1016/j.yrtph.2003.12.006 Sarmah, 2006, A global perspective on the use, sales, exposure pathways, occurrence, fate and effects of veterinary antibiotics (VAs) in the environment, Chemosphere, 65, 725, 10.1016/j.chemosphere.2006.03.026 Schrap, 2003 Schulman, 2002, A human health risk assessment of pharmaceuticals in the aquatic environment, Hum Ecol Risk Assess, 8, 657, 10.1080/20028091057141 Sim, 2011, Occurrence and distribution of pharmaceuticals in wastewater from households, livestock farms, hospitals and pharmaceutical manufactures, Chemosphere, 82, 179, 10.1016/j.chemosphere.2010.10.026 Struijs, 1996 Sumpter, 2007, Environmental effects of human pharmaceuticals, Drug Inf J, 41, 143, 10.1177/009286150704100203 Swaving, 2000 Tamtam, 2008, Occurrence and fate of antibiotics in the Seine River in various hydrological conditions, Sci Total Environ, 393, 84, 10.1016/j.scitotenv.2007.12.009 Taylor, 2008, An initial survey of unused and expired medicine take-back schemes in the European Union Thomas, 2004, The occurrence of selected human pharmaceutical compounds in UK estuaries, Mar Pollut Bull, 49, 436, 10.1016/j.marpolbul.2004.02.028 Toldrá, 2006, Methods for rapid detection of chemical and veterinary drug residues in animal foods, Trends Food Sci Technol, 17, 482, 10.1016/j.tifs.2006.02.002 Tolls, 2001, Sorption of veterinary pharmaceuticals in soils: a review, Environ Sci Technol, 35, 3397, 10.1021/es0003021 Tong, 2011, Disposal practices for unused medications around the world, Environ Int, 37, 292, 10.1016/j.envint.2010.10.002 Torniainen, 1996, The effect of pH, buffer type and drug concentration on the photodegradation of ciprofloxacin, Int J Pharm, 132, 53, 10.1016/0378-5173(95)04332-2 TOXNET, 2011 TOXNET, 2011 Trapp, 2000, Modelling uptake into roots and subsequent translocation of neutral and ionisable organic compounds, Pest Manag Sci, 56, 767, 10.1002/1526-4998(200009)56:9<767::AID-PS198>3.0.CO;2-Q Trapp, 2006, Human exposure assessment for food — one equation for all crops is not enough Travis, 1988, Bioconcentration of organics in beef, milk, and vegetation, Environ Sci Technol, 22, 271, 10.1021/es00168a005 Van de Sande-Bruinsma, 2008, Antimicrobial drug use and resistance in Europe, Emerg Infect Dis, 14, 1722, 10.3201/eid1411.070467 Vasudevan, 2009, pH-dependent ciprofloxacin sorption to soils: interaction mechanisms and soil factors influencing sorption, Geoderma, 151, 68, 10.1016/j.geoderma.2009.03.007 Versporten, 2011, European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe (1997–2009), J Antimicrob Chemother, 66, vi25 Wahlberg, 2010 Webb, 2003, Indirect human exposure to pharmaceuticals via drinking water, Toxicol Lett, 142, 157, 10.1016/S0378-4274(03)00071-7 WHO, 2012 Wiegel, 2004, Pharmaceuticals in the river Elbe and its tributaries, Chemosphere, 57, 107, 10.1016/j.chemosphere.2004.05.017 Zorita, 2009, Occurrence and removal of pharmaceuticals in a municipal sewage treatment system in the south of Sweden, Sci Total Environ, 407, 2760, 10.1016/j.scitotenv.2008.12.030 Zuccato, 2000, Presence of therapeutic drugs in the environment, Lancet, 355, 1789, 10.1016/S0140-6736(00)02270-4